Inverness Medical Innovations has announced that its previously announced acquisition of BBI Holdings, a manufacture of non-invasive lateral flow tests, was successfully completed on February 12, 2008.
Subscribe to our email newsletter
The final purchase price consisted of $123.2 million cash and approximately 251,300 shares of Inverness common stock. In addition, existing options to purchase BBI stock have been assumed and have converted into options to purchase approximately 360,000 shares of Inverness common stock.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.